Does your oncology clinical trial have an imaging component? Are you new to working with imaging core labs? An imaging core lab can provide your team with resources, knowledge, and experience that can help make your study a success.
Previous / On-Demand Webinars:
The Response Assessment in Neuro-Oncology (RANO) group provides various central nervous system-related tumor response criteria and guidance for assessments. In this webinar, MERIT will discuss the principles and recommendations of RANO response criteria for high grade glioma (HGG) and the imaging endpoint information that needs to be collected for clinical trials.
RECIST 1.1 is the standard response criteria for solid tumors and has been a basis for adaptation and variation of other response criteria such as mRECIST, irRECIST, iRECIST, and so on. In this on-demand webinar recording, MERIT discusses the principles of RECIST 1.1, the information needed to collect imaging endpoints, and special considerations while using the RECIST 1.1 criteria.
Transparent communication with prompt access to in-house experts
Deep bench of experienced and tenured staff trained in industry sponsored clinical trials, with a dedicated team for every project
We are often able to provide competitive pricing and shortened timelines for our sponsors and partners through efficiences gained from decades of experience
Proven track record supporting FDA approval of numerous products
EXCELSIORTM, our cloud-based software solution, is designed for imaging studies and is FDA 510(K) cleared for ophthalmic indications as well as HIPAA, 21 CFR Part11, and GDPR compliant. EXCELSIOR enhances the efficiency and accuracy of your imaging data collection and interpretation
MERIT’s innovative respiratory software application, CompleClinical®, simplifies and streamlines the pulmonary clinical trial process, improving the efficiency and accuracy of data capture, management, and grading of spirometry data
Personalized attention, scalable solutions, and reliable clinical trial endpoint services
Some companies tend to overpromise and underdeliver, which puts your study success at risk. If you’re looking for a clinical trial endpoint services provider that will value your partnership and make your study a priority, consider MERIT.